Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
17361
-
17362
-
17363
RICTOR silencing inhibits cell proliferation via UGCG regulation.
Published 2025“…(<b>F</b>) Fold change (mean ± SEM, <i>n</i> = 5) in different sphingolipid species reveals an increase in ceramides and a decrease in glucosylceramides in MCF-7_RICTOR<sup>SH</sup> cells compared to MCF-7 cells. …”
-
17364
Mechanical Behavior of a Novel Nanocomposite Polysulphone - Carbon Nanotubes Membrane for Water Treatment
Published 2016“…Uniaxial tensile behavior of the membranes was characterized by means of a universal material testing machine under different testing conditions. …”
Get full text
Get full text
-
17365
-
17366
-
17367
-
17368
-
17369
Cilostazol inhibits endothelin-induced calcium increase and vasoconstriction in mouse intracranial arteries. a.
Published 2013“…Arrows denote basilar artery constriction. Bar = 50 µm <b>c.</b> Cilostazol significantly decreases endothelin-induced cytosolic calcium increase. …”
-
17370
-
17371
The in vitro and in vivo effect of a chemokine inhibitor CTCE-9908 in combination with Kynurenine metabolites on tumour adhesion
Published 2025“…In the non-cancerous cell lines HaCaT and EA. hy926, there was a decrease in percentage cell number after treatment with L-kyn, phorbol 12-myristate 13-acetate (PMA), a positive control for adhesion, and CTCE-9908, suggesting a decrease in cell adhesion in the non-cancerous cell lines.…”
-
17372
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
Published 2016“…</p><p>Methods</p><p>We used the MISCAN-Cervix model to determine the optimal screening strategy for a pre-vaccination population and for vaccinated women (~80% decreased risk), assuming a willingness-to-pay of €50,000 per quality-adjusted life year gained. …”
-
17373
-
17374
-
17375
Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx
Published 2023“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”
-
17376
Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx
Published 2023“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”
-
17377
Data_Sheet_1_Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the double-blind, randomized, placebo-controlled CORVETTE-01 trial.docx
Published 2023“…</p>Results<p>Overall, 112 and 109 patients were randomized to ivermectin and placebo, respectively; 106 patients from each group were included in the full analysis set (male [%], mean age: 68.9%, 47.9 years [ivermectin]; 62.3%, 47.5 years [placebo]). …”
-
17378
-
17379
-
17380